Management of medullary thyroid cancer based on variation of carcinoembryonic antigen and calcitonin

被引：5
作者：
Wang, Bo [1 ]
Huang, Jie [2 ]
Chen, Li [3 ]
机构：
[1] Tianjin Med Univ Gen Hosp, Dept Paediat Surg, Tianjin, Peoples R China
[2] Tianjin Med Univ Gen Hosp, Dept Resp & Crit Care Med, Tianjin, Peoples R China
[3] Ludwig Maximilian Univ Munich, Klinikum Univ Munchen, Med Klin & Poliklin 4, Munich, Germany
来源：
FRONTIERS IN ENDOCRINOLOGY | 2024年 / 15卷
关键词：
medullary thyroid carcinoma (MTC); carcinoembryonic antigen (CEA); calcitonin (Ctn); perioperative management; follow-up; SERUM CALCITONIN; POSTOPERATIVE CALCITONIN; NEUROENDOCRINE TUMOR; SURGICAL-MANAGEMENT; RISK STRATIFICATION; CLINICAL CHALLENGES; ROUTINE MEASUREMENT; BASAL CALCITONIN; FREE SURVIVAL; CARCINOMA;
D O I：
10.3389/fendo.2024.1418657
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Carcinoembryonic antigen (CEA) and calcitonin (Ctn) are pivotal biomarkers in the diagnosis and management of medullary thyroid carcinoma (MTC). However, their diagnostic reliability in perioperative period remains a topic of ongoing debate. This review synthesizes researches on perioperative fluctuations in CEA and Ctn levels, and evaluates the impact of their different combinations on MTC diagnosis, treatment decisions, and prognosis. Our findings highlight it is crucial to understand and interpret the various combinations of CEA and Ctn fluctuations within a clinical context. Furthermore, to reduce diagnostic errors and improve patient outcomes, we recommend follow-up diagnostic and treatment protocols designed to address the potential pitfalls associated with the use of these biomarkers.
引用
收藏
页数：11
相关论文
共 121 条
[41]   Choroidal metastasis as initial presentation of aggressive medullary thyroid carcinoma with widespread mediastinal, brain, pituitary, bone, lung, and liver metastasis: Case report and literature review [J].
Hassan, Mohamed S. Al ;
El Ansari, Walid ;
Alater, Ahmad ;
Darweesh, Adham ;
Abdelaal, Abdelrahman .
INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2021, 87
[42]   The neurotransmitter calcitonin gene-related peptide shapes an immunosuppressive microenvironment in medullary thyroid cancer [J].
Hou, Yingtong ;
Lin, Bo ;
Xu, Tianyi ;
Jiang, Juan ;
Luo, Shuli ;
Chen, Wanna ;
Chen, Xinwen ;
Wang, Yuanqi ;
Liao, Guanrui ;
Wang, Jianping ;
Zhang, Jiayuan ;
Li, Xuyang ;
Xiang, Xiao ;
Xie, Yubin ;
Wang, Ji ;
Peng, Sui ;
Lv, Weiming ;
Liu, Yihao ;
Xiao, Haipeng .
NATURE COMMUNICATIONS, 2024, 15 (01)
[43]   The impact of preoperative calcitonin screening on the prognosis of patients with medullary thyroid cancer: a retrospective multicenter cohort study [J].
Hou, Yingtong ;
Yang, Yu ;
Chen, Gang ;
Long, Jianyan ;
He, Yufei ;
Xiong, Dandan ;
Pang, Yuyan ;
Li, Qi ;
Dong, Guojie ;
Qiao, Siqi ;
Chen, Wenke ;
Li, Xuyang ;
Zhang, Jiayuan ;
Xu, Tianyi ;
Chen, Xinwen ;
Lai, Fenghua ;
Guan, Haixia ;
Lin, Bo ;
Liu, Yihao .
ENDOCRINE, 2024, 85 (02) :827-836
[44]   Postoperative calcitonin study in medullary thyroid carcinoma [J].
Ismailov, SI ;
Pulatova, NR .
ENDOCRINE-RELATED CANCER, 2004, 11 (02) :357-363
[45]   Clinical value of [18F]FDG-PET/CT in the detection of metastatic medullary thyroid cancer [J].
Jiang, Jinjin ;
Yang, Zhongyi ;
Zhang, Yongping ;
Xu, Xiaoping ;
Wang, Mingwei ;
Hu, Silong ;
Yao, Zhifeng ;
Pan, Herong ;
Zhang, Yingjian ;
Li, Duanshu .
CLINICAL IMAGING, 2014, 38 (06) :797-801
[46]   Early postoperative calcitonin-to-preoperative calcitonin ratio as a predictive marker for structural recurrence in sporadic medullary thyroid cancer: A retrospective study [J].
Jiao, Zan ;
Wu, Tong ;
Jiang, Mingjie ;
Jiang, Shuxian ;
Jiang, Ke ;
Peng, Jin ;
Luo, Guangfeng ;
Yu, Yongchao ;
Chen, Weichao ;
Yang, Ankui .
FRONTIERS IN ENDOCRINOLOGY, 2022, 13
[47]   Clinical challenges with calcitonin-negative medullary thyroid carcinoma: three case report and a review of the literature [J].
Jingzhu, Z. ;
Xiangqian, Z. ;
Ming, G. ;
Yi, P. ;
Jiadong, C. ;
Xinwei, Y. ;
Xu Guangwei .
ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2022, 104 (03) :221-230
[48]   Extension of Prophylactic Surgery in Medullary Thyroid Carcinoma. Differences Between Sporadic and Hereditary Tumours According to Calcitonin Levels and Lymph Node Involvement [J].
Juez, L. D. ;
Mercader, E. ;
Amunategui, I ;
Febrero, B. ;
Rodriguez, J. M. ;
Gomez-Ramirez, J. .
WORLD JOURNAL OF SURGERY, 2022, 46 (04) :820-828
[49]   Postoperative biochemical remission of serum calcitonin is the best predictive factor for recurrence-free survival of medullary thyroid cancer: a large-scale retrospective analysis over 30 years [J].
Jung, Kyong Yeun ;
Kim, Seok-Mo ;
Yoo, Won Sang ;
Kim, Bup-Woo ;
Lee, Yong Sang ;
Kim, Kyung Won ;
Lee, Kyu Eun ;
Jeong, Jong Ju ;
Nam, Kee-Hyun ;
Lee, Se Hoon ;
Hah, Jeong Hun ;
Chung, Woong Youn ;
Yi, Ka Hee ;
Park, Do Joon ;
Youn, Yeo-Kyu ;
Sung, Myung-Whun ;
Cho, Bo Youn ;
Park, Cheong Soo ;
Park, Young Joo ;
Chang, Hang-Seok .
CLINICAL ENDOCRINOLOGY, 2016, 84 (04) :587-597
[50]   A Calcitonin Non-producing Neuroendocrine Tumor of the Thyroid Gland [J].
Kasajima, Atsuko ;
Cameselle-Teijeiro, Jose ;
Loidi, Lourdes ;
Takahashi, Yoshio ;
Nakashima, Noriaki ;
Sato, Satoko ;
Fujishima, Fumiyoshi ;
Watanabe, Mika ;
Nakazawa, Tadao ;
Naganuma, Hiroshi ;
Kondo, Tetsuo ;
Kato, Ryohei ;
Sasano, Hironobu .
ENDOCRINE PATHOLOGY, 2016, 27 (04) :325-331
12345678910